Start-Up Quarterly Statistics, Q3 2015

05 Nov 2015

• By Deanna Kamienski

Start-ups raised $2.57 billion in Q3. Biopharma companies penned 23 alliances; 11 acquisitions were signed, none in the diagnostics industry.

During the third quarter of 2015, start-up companies raised a total of $2.57 billion, $39 million less than last quarter. Biopharma companies pulled in an impressive $2.38 billion, 53% resulting from Series A ($598 million) and B ($655 million) rounds. All four medical device financings were Series A rounds (a total of $52 million), and five in vitro diagnostics companies combined for $140 million. (See Exhibit 1.)

Series B financings accounted for the most private money ($655 million; 28%) raised within the biopharma sector. Of the 11...